Uncommon gynecologic cancers /
Rare gynecological cancers kill all too commonly Gynecological cancer is a frightening prospect for women. It is terrifying also for physicians who need, but often can't find, guidance on how to investigate and appropriately treat the tumors. Rare cancers provide greater challenges as informati...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Chichester, England :
Wiley Blackwell,
2015.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Title Page; Copyright; Contents; List of Contributors; Preface; Part 1 General Principles; Chapter 1 Molecular Targets in Gynecologic Cancers; Introduction; Phosphoinositol 3-kinase (PI3K) pathway; Mitogen-activated protein kinase (MAPK) pathway; Human epidermal growth factor receptor 2 (HER2); Vascular endothelial growth factor (VEGF); Poly (adenosine) diphosphate [ADP]-ribose polymerase (PARP); References; Chapter 2 Imaging of Rare Gynecologic Tumors; Imaging guidelines; Imaging of uncommon ovarian malignancies; Imaging of uncommon uterine and endometrial malignancies.
- Imaging of uncommon cervical malignanciesImaging of uncommon vaginal and vulvar malignancies; Conclusion; References; Chapter 3 Pathology Overview of Rare Gynecologic Tumors; Ovary; The Uterine Corpus; Uterine Cervix; Vagina and Vulva; Fallopian Tube; Peritoneum; References; Part 2 Rare Ovarian Cancers; Chapter 4 Ovarian Clear Cell Carcinoma; Introduction; Epidemiology; Pathology; Pathogenesis; Clinical presentation; Pretreatment evaluation; Prognostic factors; Treatment; Future directions; Surveillance; Conclusions; References; Chapter 5 Mucinous Epithelial Ovarian Cancer; Introduction.
- Epidemiology Pathology; Pathogenesis; Clinical presentation; Pretreatment evaluation; Prognostic factors; Treatment; Surveillance; Conclusions; References; Chapter 6 Pseudomyxoma Peritonei; Introduction; Epidemiology; Pathology; Pathogenesis; Clinical Presentation; Pretreatment Evaluation; Treatment; Surveillance; Conclusions; References; Chapter 7 Squamous Cell Carcinoma of the Ovary; Introduction; Epidemiology; Pathology; Pathogenesis; Clinical presentation; Pretreatment evaluation; Treatment; Survival; Surgical management; Fertility-sparing/conservative surgery; Chemotherapy; Radiation.
- Surveillance Conclusions; References; Chapter 8 Endometriosis-Associated Ovarian Cancer; Introduction; Epidemiology; Pathology; Pathogenesis; Clinical presentation; Pretreatment evaluation; Treatment; Surveillance; Conclusions; References; Chapter 9 Carcinosarcoma of the Ovary; Introduction; Pathology; Pathogenesis; Clinical presentation; Pretreatment evaluation; Prognostic factors; Treatment; Surveillance; Conclusions; References; Chapter 10 Malignant Germ Cell Tumors of the Ovary; Introduction; Epidemiology; Pathology; Immature teratoma; Pathogenesis; Clinical presentation.
- Pretreatment evaluation Prognostic factors; Treatment; Surveillance; Conclusions; References; Chapter 11 Malignant Sex Cord-Stromal Tumors of the Ovary; Introduction; Epidemiology; Pathology; Pathogenesis; Clinical presentation; Pretreatment evaluation; Prognostic factors; Treatment; Surveillance; Conclusions; References; Chapter 12 Small Cell and Neuroendocrine Cancers of the Ovary; Introduction; Small cell carcinoma; NSCNEC of the ovary; Conclusions; References; Chapter 13 Carcinoid Tumors of the Ovary; Introduction; Epidemiology; Pathology; Pathogenesis; Clinical presentation.